The Darya-Varia Group is a fully integrated healthcare Company engaged in the manufacture and marketing of prescription and over the counter medicines.

Our mission is not confined to profit, but embraces the broader aim of creating value for our stakeholders - our clients, consumers, employees, principals, and shareholders.

We recruit only on the best people - dedicated healthcare professionals who relish the opportunity to work in a stimulating team oriented environment that honors personal achievement and initiative.

Our success is achieved through a combination of high performance, teamwork and a willingness to embrace new ideas and methods.

We aim to achieve sustainable profitability through prudent growth in order to create lasting value for our shareholders and employees.

We are committed to good corporate citizenship by observing the laws of the Republic of Indonesia, respecting the environment, and bettering the lives of the residents of the local communities in which we operate.

The Company

Founded in 1976 by Drs. Wim Kalona, PT Darya-Varia Laboratoria Tbk today operates two manufacturing facilities after closing two other plants in 1998 as part of the Group re-structuring.

In end of December 2001, Far East Drug, an affiliated of Unilab Group of Philippines purchased DVL Investment Limited (DVLIL), which owns 89.5% of the total shares issued by Darya-Varia, from First Pacific Group, Hong Kong.

In July 2006, DVLIL and Far East Drug (BVI) Ltd. sold their entire shares in Darya-Varia to Blue Sphere Singapore Pte. Ltd. (Blue Sphere) making Blue Sphere the majority 92.7% shareholder of Darya-Varia.

The Company is professionally managed by a team of executives with extensive experience in the multi-national pharmaceutical industry as well as other multi-national and major national corporations.

The Company, as a member of United Laboratories Inc. (Unilab Group), a leading pharmaceutical company in the region, based in Philippines conducts its business in an ethical and professional manner. The majority of its business is derived from relationship with multi-national principals.

Sales & Marketing

The Ethical Sales & Marketing units are organized according to specialty. Its strong relationship with medical practitioners nationwide, built up through the years, has equipped this dedicated team of well trained pharmaceutical professionals with the capability to effectively promote products to a wide array of doctors: from General Practitioners to Specialists of various fields.

The Over-the-Counter Sales & Marketing unit has extensive brand building experience. This unit markets over the counter brands such as NATUR-E®, SUPERTIN®, STOP COLD®, etc., employing mass media advertising such as television. Its highly competent team of marketing specialists provide full service: from brand management and merchandising to trade and direct to consumer events promotions.

Manufacturing

The Company operates two manufacturing facilities in the Greater Jakarta Area with a total land area of 14.73 hectares, with built-up area of 31,205 sq. mtrs. Which are capable of producing most pharmaceutical products.

Amongst these are soft capsules, syrups, dry syrups, tablets, film coated tablets, sugar coated tablets (dragees), lozenges, cream/ointment, injectables, eye-drops, eye ointment and contact lens care solutions. All of the factories are GMP certified.

One of the latest PT Darya-Varia Laboratoria Tbk supplement products is the Blood care.